Investment Thesis
Moderna faces a fundamental deterioration in its business with 39.9% revenue decline and operating losses of $1.4B, driven by post-COVID vaccine demand normalization. While the balance sheet remains solid with $1.9B in cash and low debt, the company is burning $630M+ annually in operations, creating an unsustainable 3-year cash runway without major business repositioning.
Strengths
- Strong balance sheet with low debt-to-equity ratio (0.08x) and minimal financial leverage
- Excellent liquidity position with 2.41x current ratio providing flexibility
- Net loss improving 20.8% year-over-year, indicating management actions are reducing losses
Risks
- Catastrophic 39.9% YoY revenue decline with no evidence of stabilization or recovery
- Operating and free cash flow deeply negative (-$630M and -$692M respectively) indicating unsustainable burn rate
- Losses so severe that profitability timeline is uncertain, threatening enterprise viability if trends continue
Key Metrics to Watch
- Revenue stabilization and growth recovery - critical indicator of business viability
- Operating cash flow trend - must move toward positive territory within 18-24 months
- Cash runway depletion rate relative to cost restructuring success
Financial Metrics
Revenue
389.0M
Net Income
-1.3B
EPS (Diluted)
$-3.40
Free Cash Flow
-692.0M
Total Assets
11.5B
Cash
1.9B
Profitability Ratios
Gross Margin
N/A
Operating Margin
-356.8%
Net Margin
-345.2%
ROE
-18.1%
ROA
-11.7%
FCF Margin
-177.9%
Balance Sheet & Liquidity
Current Ratio
2.41x
Quick Ratio
2.35x
Debt/Equity
0.08x
Debt/Assets
35.5%
Interest Coverage
N/A
Long-term Debt
590.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T19:42:50.357144 |
Data as of: 2026-03-31 |
Powered by Claude AI